Big Gut Seminars: Focus on Complex Inflammatory Bowel Disease (March 31) & Colorectal Disease (April 1)

 

Friday, March 31, 2017 and Saturday, April 1, 2017

 
NYU Langone Medical Center
550 First Avenue
Alumni Hall
New York, NY 10016

 

Brochure

 

Register Here:

IBD ONLY Online Registration

CCD ONLY Online Registration

Two Day Online Registration

Register Via Fax*

*After 12 pm on March 29, 2017, only onsite registration is available, provided the course has not reached capacity. Onsite registrants will incur an additional $20 fee. Registration is non-transferable.

 

Course Directors

Focus on Complex Inflammatory Bowel Disease (IBD)
David P. Hudesman, MD
Lisa B. Malter, MD
Feza H.Remzi, MD

Focus on Complex Colorectal Disease (CCD)
Mitchell Bernstein, MD
Seth A. Gross, MD
Gregory Haber, MD
Elliot Newman, MD

 

Course Fees

Two Day Fees

EARLY BIRD: $400 (Ends 3/1/2017 at 5:00 PM EST)
Full: $500
Reduced Fee (Allied Healthcare Professionals): $150
Residents and Fellows: $75
NYU Langone/Lutheran Physician*: $350
NYU Langone/Lutheran Reduced (Allied Healthcare Professionals)*: $100

 

IBD Only OR CCD Only

EARLY BIRD: $225 (Ends 3/1/2017 at 5:00 PM EST)
Full: $275
Reduced Fee (Allied Healthcare Professionals): $100
Residents and Fellows: $50
NYU Langone/Lutheran Physician*: $200
NYU Langone/Lutheran Reduced (Allied Healthcare Professionals)*: $75

*Must provide valid NYU Langone / NYU Lutheran ID

Target Audience

Inflammatory Bowel Disease- Gastroenterologists, surgeons, hepatologists, medical oncologists, interventional radiologists, radiologists, pathologists, gastroenterology and hepatology fellows, and other disciplines involved in the care of patients who have inflammatory bowel disease.

Complex Colorectal Disease- Gastroenterologists, surgeons, hepatologists, medical oncologists, interventional radiologists, radiologists, pathologists, gastroenterology and hepatology fellows, and other disciplines involved in the care of patients who are at risk for or have benign or malignant colorectal disease.

Course Description

Inflammatory Bowel Disease — Inflammatory bowel disease is a challenging condition, requiring an integrated multidisciplinary and often innovative approach to care. The Big Gut Seminars: Focus on Complex Inflammatory Bowel Disease (IBD) is an interactive conference, focused on the pathophysiology, diagnosis, and treatment of complex inflammatory bowel disease, targeted to a multidisciplinary audience of gastroenterologists, surgeons, hepatologists, medical oncologists, interventional radiologists, radiologists, pathologists, and others involved in the care of patients with these conditions. This second annual conference will feature a multidisciplinary faculty of national leaders in the field and an interactive format including a lightning round of short didactic presentations, point-counterpoint debates, and multidisciplinary panel discussion of challenging, complex patient cases. Research in the pathophysiology of IBD; new treat-to-target management paradigms and approaches to treatment; disease and drug monitoring; surgery as an integral part of care; and special considerations, such as the transition to adult care, will be highlighted.

Complex Colorectal Disease — Colorectal disease, both benign and malignant, can pose challenges in diagnosis and treatment, requiring an integrated multidisciplinary and often innovative approach to care. The Big Gut Seminars: Focus on Complex Colorectal Disease (CCD) is an interactive conference, focused on pathophysiology, screening, diagnosis, and treatment in colorectal disease, targeted to a multidisciplinary audience of gastroenterologists, surgeons, hepatologists, medical oncologists, interventional radiologists, radiologists, pathologists, and others involved in the care of patients with these conditions. This conference will feature a multidisciplinary faculty of national leaders in the field and an interactive format, including a lightning round of short didactic presentations, point-counterpoint debates, and multidisciplinary panel discussion of challenging, complex patient cases. Research in the pathophysiology of benign and malignant colorectal disease; new recommendations for colorectal cancer screening; optimization of adenoma detection rate; management of difficult polyps; new endoscopic and surgical technologies; treatment algorithms; and current and emerging issues in the diagnosis and treatment of challenging colorectal conditions, such as complicated diverticular disease, gastrointestinal bleed, C difficile infection, hereditary syndromes, and cancer.

Educational Objectives

Inflammatory Bowel Disease — At the conclusion of this activity, participants should be able to:

  • Identify the factors involved in disease monitoring and the treat-to-target management paradigm in inflammatory bowel disease, and identify ways to incorporate this approach to care into their clinical practices

  • Identify and apply to practice the steps involved in drug monitoring to maintain remission, optimize management, and determine when to switch treatment regimens

  • Identify new treatment options, their risks and benefits, monitoring needs, and ways to incorporate them into their practices in inflammatory bowel disease

  • Identify appropriate ways to apply to their practice new and evolving endoscopic and surgical approaches, technologies, and techniques

Complex Colorectal Disease — At the conclusion of this activity, participants should be able to:

  • Identify key criteria in the differential diagnoses and treatment recommendations for colorectal conditions, such as diverticular disease, gastrointestinal bleed, C difficile infection, and cancers

  • Identify and apply to practice the current recommendations for colorectal cancer screening and surveillance

  • Identify appropriate ways to apply to their practice new and evolving endoscopic and surgical approaches, technologies, and techniques

  • Identify quality considerations and metrics in the screening, diagnosis, and treatment of colorectal diseases and conditions

Statement of Need

Inflammatory Bowel Disease

Physicians need to be aware of current and evolving new disease monitoring approaches and management paradigms in the care of patients with inflammatory bowel disease. Physicians need to be aware of the importance of utilizing up-to-date drug monitoring strategies to personalize the management of inflammatory disease for each patient. Physicians need to be aware of the current and evolving data on new treatment options, their risks and benefits, and monitoring recommendations for patients with inflammatory bowel disease. Physicians need to be aware of new and evolving endoscopic and surgical approaches, technologies, and techniques and when and how they can be best applied in clinical practice for patients with inflammatory bowel disease. Physicians need to be able to identify the factors that play a role in determining the personalized approach to care for individual patients who are pre-conception, are pregnant, are elderly, or are transitioning from pediatric to adult care. Physicians need to be able to identify current and emerging factors and recommendations in the surveillance and management of dysplasia and colorectal cancer in patients with inflammatory bowel disease.

Complex Colorectal Disease 

Physicians need to be aware of new diagnostic technologies and treatment algorithms in the care of patients with complicated colorectal diseases and conditions. Physicians need to be aware of the latest recommendations for colorectal cancer screening and surveillance. Physicians need to be aware of new and evolving endoscopic and surgical approaches, technologies, and techniques and when and how they can be best applied in clinical practice for patients with colorectal diseases and conditions. Physicians need to be able to identify and apply the indicated quality metrics related to the screening, diagnosis, and treatment of colorectal diseases and conditions.

Credit Designation Statement

Inflammatory Bowel Disease — The NYU Post-Graduate Medical School designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Complex Colorectal Disease — The NYU Post-Graduate Medical School designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

 

Inflammatory Bowel Disease — Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

Complex Colorectal Disease — Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

Accreditation Statement

The NYU Post-Graduate Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Refund Policy

In order to request a refund, you must email maria.mercado@nyumc.org no later than 14 days prior to the first day of the course. An administrative fee of $75 will be deducted from your refund. Cancellations or no-shows after this date are not eligible for a refund. 

Course Cancellation Policy

If a course is cancelled due to inclement weather, insufficient enrollment, or any other reason, NYU PGMS will refund registration fees in full. NYU PGMS will provide at least two weeks’ advance notice if cancelling due to insufficient enrollment and as soon as possible in all other circumstances. NYU PGMS is not responsible for any airfare, hotel, or other non-cancellable costs incurred by the registrant.